All Stories

  1. In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome

    Article • Pharmaceuticals, November 2022, MDPI AG

    Dr. Marco A Loza-Mejía

  2. High Fructose and High Fat Diet Impair Different Types of Memory through Oxidative Stress in a Sex- and Hormone-Dependent Manner

    Article • Metabolites, April 2022, MDPI AG

    Dr. Marco A Loza-Mejía

  3. Does the Fetus Limit Antibiotic Treatment in Pregnant Patients with COVID-19?

    Article • Antibiotics, February 2022, MDPI AG

    Dr. Marco A Loza-Mejía

  4. p21-Activated Kinase 1 Promotes Breast Tumorigenesis via Phosphorylation and Activation of the Calcium/Calmodulin-Dependent Protein Kinase II

    Article • Frontiers in Cell and Developmental Biology, January 2022, Frontiers

    Dr. Genaro Patino-Lopez, Dr. Marco A Loza-Mejía

  5. Recent advances in PTP1B signaling in metabolism and cancer

    Article • Bioscience Reports, November 2021, Portland Press Ltd.

    Dr. Marco A Loza-Mejía

  6. Inflammation Parameters Associated with Metabolic Disorders: Relationship Between Diet and Microbiota

    Article • Metabolic Syndrome and Related Disorders, November 2021, Mary Ann Liebert Inc

    Dr. Marco A Loza-Mejía

  7. In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model

    Article • Pharmaceuticals, September 2021, MDPI AG

    Dr. Marco A Loza-Mejía

  8. Synthesis, in silico, and in vivo anti-inflammatory evaluation of 3β-cinnamoyloxy substituted pregna-4,16-diene-6,20-diones derivatives

    Article • Journal of Biomolecular Structure and Dynamics, September 2021, Taylor & Francis

    Dr. Marco A Loza-Mejía

  9. In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches

    Article • Molecules, January 2021, MDPI AG

    Dr. Marco A Loza-Mejía

  10. Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study

    Article • International Immunopharmacology, January 2021, Elsevier

    Dr. Marco A Loza-Mejía

  11. Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19

    Article • Medical Hypotheses, November 2020, Elsevier

    Dr. Marco A Loza-Mejía

  12. Chemistry, Biological Activities and In Silico Bioprospection of Sterols and Triterpenes from Mexican Columnar Cactaceae

    Article • Molecules, April 2020, MDPI AG

    Dr. Marco A Loza-Mejía

  13. A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis

    Article • Frontiers in Chemistry, March 2020, Frontiers

    Dr. Marco A Loza-Mejía

  14. Synthesis and Biological Studies of (+)-Liquiditerpenoic Acid A (Abietopinoic Acid) and Representative Analogues: SAR Studies

    Article • Journal of Natural Products, March 2019, American Chemical Society (ACS)

    Dr Miguel A González-Cardenete, Dr. José M. Padrón, Dr. Marco A Loza-Mejía

  15. α-Glucosidase inhibitors from a mangrove associated fungus, Zasmidium sp. strain EM5-10

    Article • BMC Chemistry, February 2019, Springer Science + Business Media

    Dr. Marco A Loza-Mejía

  16. Synthesis, In Silico, and In Vitro Evaluation of Long Chain Alkyl Amides from 2-Amino-4-Quinolone Derivatives as Biofilm Inhibitors

    Article • Molecules, January 2019, MDPI AG

    Dr. Marco A Loza-Mejía

  17. In Silico Studies on Compounds Derived from Calceolaria: Phenylethanoid Glycosides as Potential Multitarget Inhibitors for the Development of Pesticides

    Article • Biomolecules, October 2018, MDPI AG

    Dr. Marco A Loza-Mejía

  18. Synthesis, cytotoxic activity, DNA binding and molecular docking studies of novel 9-anilinothiazolo[5,4-b]quinoline derivatives

    Article • Medicinal Chemistry Research, September 2016, Springer Science + Business Media

    Dr. Marco A Loza-Mejía

  19. fused quinolones

    Article • Heterocyclic Communications, January 2016, De Gruyter

    Dr. Marco A Loza-Mejía, Alfonso Lira-Rocha

  20. Sterols and triterpenoids as potential anti-inflammatories: Molecular docking studies for binding to some enzymes involved in inflammatory pathways

    Article • Journal of Molecular Graphics and Modelling, November 2015, Elsevier

    Dr. Marco A Loza-Mejía

  21. Phytochemical composition, antiparasitic and α–glucosidase inhibition activities from Pelliciera rhizophorae

    Article • Chemistry Central Journal, September 2015, Springer Science + Business Media

    Dr. Marco A Loza-Mejía

  22. Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation

    Article • European Journal of Medicinal Chemistry, June 2011, Elsevier

    Dr. Marco A Loza-Mejía

  23. Molecular modeling of tricyclic compounds with anilino substituents and their intercalation complexes with DNA sequences

    Article • Journal of Molecular Graphics and Modelling, June 2009, Elsevier

    Dr. Marco A Loza-Mejía

  24. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure–activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives

    Article • Bioorganic & Medicinal Chemistry, May 2009, Elsevier

    Dr. Marco A Loza-Mejía

  25. Synthesis, cytotoxic evaluation, and DNA binding of novel thiazolo[5,4-b]quinoline derivatives

    Article • Bioorganic & Medicinal Chemistry, February 2008, Elsevier

    Dr. Marco A Loza-Mejía